![]() |
市場調査レポート
商品コード
1597294
マイクロカテーテル市場:製品別、用途別、デザイン別、エンドユーザー別、地域別、機会、予測、2017年~2031年Microcatheters Market Assessment, By Product, By Application, By Design, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
||||||
カスタマイズ可能
|
マイクロカテーテル市場:製品別、用途別、デザイン別、エンドユーザー別、地域別、機会、予測、2017年~2031年 |
出版日: 2024年11月26日
発行: Market Xcel - Markets and Data
ページ情報: 英文 221 Pages
納期: 3~5営業日
|
世界のマイクロカテーテルの市場規模は、予測期間の2024年~2031年に5.55%のCAGRで拡大し、2023年の9億939万米ドルから2031年には14億93万米ドルに成長すると予測されています。世界のマイクロカテーテル市場は医療機器市場の重要な一部です。慢性疾患の有病率の上昇、低侵襲手術の採用増加、技術革新などの要因が市場を牽引しています。
マイクロカテーテルは主に低侵襲手術で利用され、薬やデバイスを投与できる薄肉で小口径のチューブとして特徴付けられます。このような極細のカテーテルは、動脈にカテーテルを誘導するのに適しているため、経皮的冠動脈および神経血管処置に頻繁に使用されます。マイクロカテーテルはステム型にすることもできますが、予約注文時に一定の形状で製造されることもあります。ステアラブル・マイクロカテーテルは、高齢患者の血管流量を増加させるバルーンデリバリーなどの心臓用途に採用されています。マイクロカテーテルは、診断や治療の目的で、ガイドワイヤーやその他のインターベンション器具の挿入や交換に使用することができます。ほとんどのマイクロカテーテルには、潤滑性のあるコーティングが施され、貫通や送達を容易にするために、ステアラブルまたはアングルドチップが内蔵されています。親水性の被覆は複雑な血管系を通過する際のナビゲーションを向上させ、コイルピッチは柔軟性と近位への押しやすさを促進します。マイクロカテーテルは経皮的冠動脈インターベンション(PCI)でも広く利用されています。石灰化病変やオスチアル病変、曲がりくねった冠動脈構造、多枝病変、左主幹狭窄などはすべて、老人患者に多くみられます。
当レポートでは、世界のマイクロカテーテル市場について調査し、市場の概要とともに、製品別、用途別、デザイン別、エンドユーザー、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Global microcatheters market is projected to witness a CAGR of 5.55% during the forecast period 2024-2031, growing from USD 909.39 million in 2023 to USD 1400.93 million in 2031. The global microcatheters market is an important part of the medical device market. The market is being driven by factors such as the increasing prevalence of chronic diseases, rising adoption of minimally invasive surgeries, and technological innovations.
Microcatheters are mostly utilized in minimally invasive surgeries and are characterized as thin-walled, small-diameter tubes via which medications and devices can be administered. These tiny catheters are frequently used for percutaneous coronary and neurovascular procedures because they are perfect for guiding these catheters into arteries. Microcatheters can be stem-shaped but are also manufactured in a certain shape during preorder. Steerable microcatheters have been employed in cardiac applications, including balloon delivery, to increase vascular flow in elderly patients. Microcatheters can be used to insert and replace guidewires and other interventional devices for diagnostic and therapeutic purposes. Most microcatheters contain a lubricious coating and an integrated steerable or angled tip to facilitate penetration and delivery. The hydrophilic covering improves navigation through convoluted vasculatures, while the coil pitch promotes flexibility and proximal pushability. Microcatheters are also widely utilized in percutaneous coronary intervention (PCI). Calcified and ostial lesions, tortuous coronary anatomy, multivessel disease, and left main stem stenosis are all more common in geriatric patients.
In November 2023, Transit Scientific Inc., a Utah-based medical device company, received FDA approval for its next-generation microcatheter, the XO Cath. This innovative device is designed to accurately deliver embolic agents, marking a significant advancement in microcatheter technology. The XO Cath microcatheter is engineered to offer unprecedented levels of trackability, torque responsiveness, and embolic compatibility, thereby enhancing the precision and effectiveness of therapy administration.
Increasing Prevalence of Chronic Diseases Drive Market Growth
The rising prevalence of cardiovascular and neurovascular diseases is a key contributor to the growing need for microcatheters. Chronic cardiac disorders such as myocardial infarction, angina, atherosclerosis, and ischemic stroke are on the rise and frequently necessitate minimally invasive procedures in which microcatheters play an important role. Neurovascular illnesses such as brain aneurysms and blood clots also play a key role in the need for these tiny, flexible catheters used to reach distant anatomy and administer therapies. The aging population is particularly sensitive to these diseases, which fuels the demand for better microcatheter technologies to provide precise diagnosis and treatment with less patient harm. As per a report from the British Heart Foundation, around 200 million people have coronary heart disease globally, out of which 57.89% of the patients were male and 42.11% were female.
Rising Adoption of Minimally Invasive Surgeries Positively Impact Market Growth
The growing global demand for microcatheters is driven mostly by the increased adoption of minimally invasive surgical procedures. Minimally invasive surgeries, which use small incisions and enhanced imaging guidance, are becoming increasingly common in several medical areas, including cardiology, neurovascular, and cancer. Microcatheters are crucial in facilitating these treatments because they allow access to distant areas of the body, distribute therapeutic medicines, and facilitate the use of embolic materials. According to the American Society of Plastic Surgeons, in 2022, 26.2 million surgical and minimally invasive cosmetic and reconstructive operations were carried out in the United States. Since 2019, the number of surgeries performed has increased by 19%.
Cardiovascular Segment Holds the Highest Share in the Global Microcatheters Market
Microcatheters are often used in cardiovascular treatments because of their capacity to perform complex interventions and navigate complicated arterial anatomy. They are very effective in percutaneous coronary interventions (PCI) to treat difficult lesions such as bifurcations, ostial lesions, calcified arteries, and chronic total occlusions (CTOs). Microcatheters support guidewires, allow the exchange of guidewires, and help administer therapeutic devices like balloons and stents. They are available in a variety of configurations, including single-lumen, dual-lumen, steerable, and angled tip designs, allowing operators to choose the most suitable microcatheter depending on anatomical and lesion features. The introduction of microcatheters has broadened the scope of percutaneous coronary intervention by making it possible to treat complicated lesions that were previously considered high-risk or inappropriate for treatment.
Single-Lumen Microcatheters Dominate the Market
Single-lumen microcatheters are the most widely used microcatheters globally due to their simplicity and effectiveness in various interventional procedures, particularly in cardiology. They account for a significant share of the global microcatheters market, primarily because they provide reliable support for guidewires, allowing for easy navigation through complex vascular structures. Their design facilitates reshaping and wire exchanges without displacing the catheter from the vessel entry, which is crucial during delicate procedures. In July 2024, Transit Scientific LLC reported the successful clinical deployment of the XO Cath, an embolic delivery single-lumen microcatheter suited for interventional procedures. A patient with prostatic artery embolization (PAE) was treated with a single-lumen embolic delivery microcatheter, which had a considerable arterial blockage and demonstrated the microcatheter's capabilities, notably its mobility while passing through the arteries.
Future Market Scenario (2024-2031F)
Integration With Medical Imaging Technologies: Microcatheters will be integrated with advanced imaging technologies such as intravascular ultrasound, optical coherence tomography, and magnetic resonance imaging. This integration will provide real-time visualization and guidance during procedures, improving the accuracy and efficiency of minimally invasive surgeries.
Introduction of New Materials: The microcatheters market is expected to see significant advancements in material science, leading to the development of more flexible, durable, and biocompatible materials.
Development of Smart Catheters: The market will likely witness the development of smart catheters equipped with sensors, actuators, and microprocessors. These smart catheters will be capable of monitoring and adjusting their performance in real-time, enhancing the precision and safety of procedures.
New Applications: Microcatheters are expected to find new applications in areas such as regenerative medicine, gene therapy, and targeted drug delivery. Developing microcatheters with specialized coatings and delivery systems will enable the precise delivery of therapeutic agents to specific tissues and organs, opening new avenues for treatment and research.
Key Players Landscape and Outlook
The microcatheter market is growing faster, fostering several local and global players. The market is quite stimulated with new regulatory approvals and product launches. The market has witnessed significant deals, including acquisitions, regulatory approvals, and product launches. For instance, in March 2024, the Food and Drug Administration (FDA) approved Emblox Inc.'s Soldier High Flow Microcatheter. The microcatheter improves flow rates while using the same ultra-thin wall (UTW) technology and superior design. The UTW technology allows for a smaller outer diameter while keeping the highest interior lumen count, thereby increasing the flow rate twofold.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.